(Q38002923)

26 August 2017

title

Inhibition of placenta growth factor with TB-403: a novel antiangiogenic cancer therapy (English)

1 reference

26 August 2017

main subject

angiogenesis inhibitor

1 reference

Dorte Lisbet Nielsen

1

1 reference

26 August 2017

Lisa Sengeløv

series ordinal

2

1 reference

26 August 2017

language of work or name

English

0 references

publication date

16 April 2012

1 reference

Expert Opinion on Biological Therapy

26 August 2017

published in

1 reference

26 August 2017

volume

12

1 reference

26 August 2017

issue

6

1 reference

26 August 2017

page(s)

795-804

1 reference

Current insights on the biology and clinical aspects of VEGF regulation

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Bevacizumab: current updates in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Antiangiogenesis agents in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Mechanisms of resistance to antiangiogenesis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Current status and future prospects for anti-angiogenic therapies in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

The biology of VEGF and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

VEGF receptor protein-tyrosine kinases: structure and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

VEGFs and receptors involved in angiogenesis versus lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Positive and negative modulation of angiogenesis by VEGFR1 ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Differential roles of vascular endothelial growth factor receptor-1 and receptor-2 in angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Inhibition of choroidal neovascularization by blocking vascular endothelial growth factor receptor tyrosine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

A placental growth factor variant unable to recognize vascular endothelial growth factor (VEGF) receptor-1 inhibits VEGF-dependent tumor angiogenesis via heterodimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Placental growth factor (PlGF) enhances breast cancer cell motility by mobilising ERK1/2 phosphorylation and cytoskeletal rearrangement

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Increased melanoma growth and metastasis spreading in mice overexpressing placenta growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

VEGFR1 activity modulates myeloid cell infiltration in growing lung metastases but is not required for spontaneous metastasis formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

PlGF blockade does not inhibit angiogenesis during primary tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Placenta growth factor (PlGF) mRNA expression in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Expression of Placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Placenta growth factor expression is correlated with survival of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Expression of placenta growth factor: an independent factor for prediction of progression and prognosis of oral cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Placenta growth factor not vascular endothelial growth factor A or C can predict the early recurrence after radical resection of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

"Antimyeloangiogenic" therapy for cancer by inhibiting PlGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

VEGFR1-activity-independent metastasis formation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Latent bone metastasis in breast cancer tied to Src-dependent survival signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Targeting the tumour vasculature: insights from physiological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Drug resistance associated with antiangiogenesis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Pathways mediating VEGF-independent tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Modes of resistance to anti-angiogenic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Angiogenesis in life, disease and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Molecular mechanisms and clinical applications of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Combined targeting of EGFR-dependent and VEGF-dependent pathways: rationale, preclinical studies and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Angiogenesis: a target in solid tumors, also in leukemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Adenovirus-Mediated Gene Transfer of Placental Growth Factor to Perivascular Tissue Induces Angiogenesis via Upregulation of the Expression of Endogenous Vascular Endothelial Growth Factor-A

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

Further Pharmacological and Genetic Evidence for the Efficacy of PlGF Inhibition in Cancer and Eye Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.679655

10.1517/14712598.2012.679655

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference